Business & Finance Roundup: MusclePharm, ChromaDex, KonaRed And VDF
This article was originally published in The Tan Sheet
Executive Summary
MusclePharm wants out of manufacturing space; ChromaDex ingredient In NIH study and NDI from FDA; and KonaRed, VDF expand collaboration.
You may also be interested in...
Anti-Aging Supplement Moves Step Closer To EU Launch With EFSA Approval
ChromaDex' dietary supplement Niagen, marketed to help US consumers "age better", has taken a step closer to EU launch with a positive opinion by the European Food Safety Authority.
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.